Meet the 7%-Yielding Stock That's Down 20%. Here's Why Investors Should Take a Closer Look.

Campbell’s (CPB) is framed as “deeply undervalued,” trading slightly above $20/share with trailing and forward P/E around 11 and PEG below 1, despite the stock being down ~20% YTD. The company’s Q3 FY2026 net sales declined 4%, while it pursues cost protection and portfolio growth, including its 2024 $2.7B acquisition of Rao’s. It also pays a quarterly dividend of $0.39/share (yielding over 7%), supported by investments in AI/data to better understand shifting shopper preferences.

Analysis

CPB is less a turnaround story than a balance between defensive cash flow and structurally low organic growth. The equity can look optically cheap at ~11x earnings and a high dividend yield, but the market will keep discounting it if volume stays negative and mix only improves through acquired brands rather than true category share gains. The key question is whether recent portfolio changes create incremental growth or just re-label a slow-growth staples franchise with higher financial leverage and integration risk.

Second-order winners are private-label grocery suppliers and the stronger branded peers that can steal shelf space if CPB uses price/promotional support to defend share. If the company leans on margin protection, the risk is that it loses units to cheaper store brands; if it leans on promotion, the risk is that earnings quality deteriorates and the dividend becomes the main support for the stock rather than a growth re-rating. That makes the setup more sensitive to scanner data and gross margin trends than to management narrative over the next 1-3 months.

The contrarian miss is that AI/data investment in consumer staples usually trims SG&A slowly; it rarely offsets weak demand quickly enough to matter for the stock. Rao’s can help mix, but acquisition-led growth often carries a lower-quality multiple if investors worry about goodwill, leverage, and post-close synergy realization. Over 6-18 months, this is a valuation-versus-execution story: if organic sales and margin stability do not improve, CPB can remain a classic value trap despite the yield.

Key Decisions for Investors

• Do not chase CPB on the article-driven bounce; require evidence of 2 consecutive months of stable scanner sales and gross margin before considering a long entry.
• Relative-value idea: short CPB / long MDLZ or GIS over 1-3 months if grocery trade-down persists; CPB has more downside to volume disappointment and acquisition scrutiny.
• Watch the next earnings print for organic growth, not adjusted EPS: if net sales remain negative and the dividend consumes too much FCF, the yield becomes a trap rather than support.
• For event-driven traders, consider a small bearish option structure on CPB into earnings only if the stock rallies back toward the mid-$20s; risk/reward improves if guidance is still reliant on cost cuts rather than demand recovery.
• Set a falsifier alert: if CPB delivers sustained organic sales growth and margin expansion without additional promo spend, the bear case weakens and the multiple can re-rate toward other defensive staples.